Diverse perspectives on science and medicine
It was September 2013 when I first heard of SynBioBeta: the leading community of entrepreneurs, investors, policy makers and enthusiasts devoted to the responsible growth of the synthetic biology field. In that occasion, John Cumbers,
0000-0003-0319-5416Whether it was academic leaders, startup entrepreneurs, or seasoned biotechnology veterans speaking, it was hard to avoid thinking of how Silicon Valley loomed over the discussions of synthetic biology’s path forward. From the snappy startup pitches
0000-0003-0319-5416Next month, Synbiobeta is coming to San Francisco for the 5th Annual SynBioBeta SF 2016 (#SBBSF16). Like other Synbiobeta events it tries to bring together the industrial and academic players in the synthetic biology field to
Last week industry leaders, entrepreneurs, innovators, and investors in the Synthetic Biology space convened at Imperial College for SynBioBeta London 2016. During the event, Eric van der Helm provided rel-time updates from inside the sessions via
